AntriaBio, Inc. to Present at the Third Annual Marcum MicroCap Conference on Thursday, May 29, 2014
May 22, 2014 07:35 ET
|
AntriaBio
MENLO PARK, CA--(Marketwired - May 22, 2014) - AntriaBio, Inc. (OTCQB: ANTB) a biopharmaceutical corporation focused on developing novel therapeutics to treat patients with diabetes and metabolic...
AntriaBio, Inc. Establishes Manufacturing and Laboratory Facility in Colorado
May 12, 2014 07:35 ET
|
AntriaBio
MENLO PARK, CA--(Marketwired - May 12, 2014) - AntriaBio, Inc. (OTCQB: ANTB) (OTCQB: ANTBD) (ticker will revert back to ANTB on May 21, 2014), a biopharmaceutical corporation focused on developing...
AntriaBio, Inc. Announces 1-for-6 Reverse Stock Split
May 01, 2014 08:05 ET
|
AntriaBio, Inc.
MENLO PARK, CA--(Marketwired - May 1, 2014) - AntriaBio, Inc. (OTCQB: ANTB), a biopharmaceutical company focused on developing novel therapeutics to treat patients with diabetes and metabolic...
AntriaBio, Inc. Launches Digital Corporate Communication Channels
April 30, 2014 08:05 ET
|
AntriaBio Inc.
MENLO PARK, CA--(Marketwired - Apr 30, 2014) - AntriaBio, Inc. (OTCQB: ANTB), a biopharmaceutical company focused on developing novel therapeutics to treat patients with diabetes and metabolic...
AntriaBio Announces Formation of Scientific Advisory Board
April 23, 2014 08:12 ET
|
AntriaBio
MENLO PARK, CA--(Marketwired - Apr 23, 2014) - AntriaBio, Inc. (OTCQB: ANTB), a biopharmaceutical company focused on developing novel therapeutics to treat patients with diabetes and metabolic...
AntriaBio, Inc. Announces $10 Million Private Placement
April 02, 2014 07:35 ET
|
AntriaBio
MENLO PARK, CA--(Marketwired - Apr 2, 2014) - AntriaBio, Inc. (OTCQB: ANTB), a biopharmaceutical company focused on developing novel therapeutics for the diabetes market, announced today that in the...
AntriaBio, Inc. to Present at 26th Annual ROTH Conference
March 06, 2014 08:05 ET
|
AntriaBio, Inc.
MENLO PARK, CA--(Marketwired - Mar 6, 2014) - AntriaBio, Inc. (OTCQB: ANTB), a biopharmaceutical company focused on developing novel therapeutics for the diabetes market, announced today that Nevan...
AntriaBio to Present at 16th Annual BIO CEO & Investor Conference on Tuesday, February 11, 2014
February 05, 2014 08:05 ET
|
AntriaBio Inc.
MENLO PARK, CA--(Marketwired - Feb 5, 2014) - AntriaBio, Inc. (OTCQB: ANTB), a biopharmaceutical company focused on developing novel therapeutics for the diabetes market, announced today that the...
AntriaBio Announces Closing of Bridge Financing
January 16, 2014 10:06 ET
|
AntriaBio
MENLO PARK, CA--(Marketwired - Jan 16, 2014) - AntriaBio, Inc. (OTCQB: ANTB), a biopharmaceutical company focused on developing novel therapeutics for the diabetes market, announced today that it...
AntriaBio Granted European Patent Allowance for Method of Preparing Site-Specific Protein Conjugates
July 24, 2013 08:30 ET
|
AntriaBio, Inc.
MENLO PARK, CA--(Marketwired - Jul 24, 2013) - AntriaBio, Inc. (OTCQB: ANTB) announced today that it has received an allowance from the European Patent Office for Patent Application No. 04759347.0...